Trial intelligence / Profile preview

Ketoprofen Cataplasms for Pain Relief in Knee Osteoarthritis (Randomized Controlled Trial)

ChiCTR2400094325Phase 4Not yet recruiting

Sponsor
Affiliated Zhongshan Hospital of Dalian University
Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ketoprofen in osteoarthritis (OA) and knee osteoarthritis (OA) (2 arms), sponsored by Affiliated Zhongshan Hospital of Dalian University. Primary endpoint: Total effective rate. Planned start Dec 2024; status: not yet recruiting.

02

Drugs

ketoprofen
03

Conditions

osteoarthritis (OA)knee osteoarthritis (OA)

Beyond the preview

Go deeper on ChiCTR2400094325.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400094325.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call